Objective: The immediate cause of obesity is the massive deposition of subcutaneous and visceral fat attributing to the continuous proliferation and differentiation of preadipocytes. The identification of the underlying molecular mechanisms of preadipocytes differentiation is urgent, and will have an important role in plastic and reconstructive surgical procedures. Methods: Two small hairpin RNA (shRNA)-mediated RNA interference plasmids have been constructed on the basis of the activity of H1 promoter-driven expression vector psiRNA-hH1neo to suppress the expression of angiotensinogen (AGT) in human preadipocytes-visceral (HPA-v). Subsequently, glycerol-3-phosphate dehydrogenase (G3PDH) activity and intracytoplasmic lipids content were detected during the process of HPA-v differentiation. Results: Small hairpin RNA-expressing vectors have been successfully constructed to suppress the expression of AGT significantly. Both intracytoplasmic lipids content and G3PDH activity decreased to a certain extent compared with that in the control group in the whole process of HPA-v differentiation. Conclusions: Two shRNA-mediated AGT-targeting plasmids inhibited the process of HPA-v differentiation to a certain extent. However, the accumulation of intracytoplasmic lipids was not exclusively determined by the expression of AGT, and it may also be regulated by other factors. In conclusion, this study provided a method to inhibit the process of preadipocytes differentiation, and it may have a role in obesity treatment and adipose tissue engineering application.
Introduction
Preadipocytes are fibroblast-like cells that accumulate a large number of triacylglycerols (TAG) and become round in shape during the process of preadipocyte-adipocyte conversion or differentiation. 1 Obesity and specifically the deleterious form, visceral adiposity, is a fast-growing serious health problem that causes a considerable variety of obesity-related diseases, such as hypertension, cardiovascular diseases and diabetes mellitus. [2] [3] [4] [5] It is known that the underlying cause of obesity is the massive accumulation of subcutaneous and visceral fat as a result of the continuous proliferation and differentiation of preadipocytes. Therefore, molecular identification of adipogenesis during preadipocytes differentiation may strongly promote the understanding of obesity and obesity-associated diseases. Moreover, large numbers of plastic and reconstructive surgical procedures are performed each year to repair adipose tissue defects that are caused by traumatic injury, tumor resection and congenital defects. 6 Preadipocytes are considered more advantageous than mature adipocytes in adipose tissue engineering, owing to their proliferative capabilities. 7 As a result, exhaustive exhibition and purposeful control of preadipocytes differentiation will also have a role in repairing adipose tissue defects. Angiotensin II (Ang II), the final effector of the reninangiotensin system (RAS), is derived from the precursor angiotensinogen (AGT), and results in vasoconstriction and in the release of aldosterone. It is suggested that Ang II is involved in preadipocytes differentiation and obesity development for its contribution toward increasing the TAG content and lipogenic enzymes activity significantly. [8] [9] [10] Generally, in circulating RAS, AGT is initially produced in the liver and converted into decapeptide angiotensin I (Ang I) in plasma under the cleavage of renin. Finally, octapeptide Ang II is generated by cutting Ang I with angiotensinconverting enzyme. In addition, components of RAS could also be produced in some tissues (local RAS or tissue RAS), such as adipose tissue, brain, heart and so on. [11] [12] [13] [14] Furthermore, Ang II can also be generated by enzymes of the nonrenin-angiotensin system, such as cathepsin D and cathepsin G. [15] [16] [17] [18] So far, it is generally believed that Ang II is derived from AGT, irrespective of which way is chosen for its formation. Generally, the complex process of preadipocytes differentiation includes a cascade of transcriptional events, such as the expression of CCAAT/enhancer-binding protein-a (C/EBPa) and peroxisome proliferator-activated receptor-g, which were regulated by hormonal and nutritional signaling. 19, 20 In our previous study, 18 the expression changes of the components of Ang II pathways and several adipokines were detected using quantitative real-time reverse transcription-PCR (RT-PCR) during human preadipocytesvisceral (HPA-v) differentiation. In these studies, we tried to construct two small hairpin RNA (shRNA)-mediated genesilencing vectors to explore their suppression on the expression of AGT, and to investigate the changes of cellular morphology, the activities of glycerol-3-phosphate dehydrogenase (G3PDH) and the inhabitation effects on the differentiation of HPA-v.
Materials and methods

Plasmid construction
Two different target sequences (AGT1 and AGT2) have been chosen for shRNA-mediated gene silencing against AGT mRNA on the basis of the reference sequence (GenBank accession number: NM_000029) using Ambion's siRNA Target Finder (http://www.ambion.com/techlib/misc/siRNA_ finder.html). In addition, a negative control sequence (AGT0) was designed randomly, and it presented no significant match to any gene when it was submitted to a BLAST search. On the basis of the sequences above, oligonucleotides were designed following the rules of previous descriptions (Table 1) . [21] [22] [23] All the single-stranded oligonucleotides were commercially synthesized by Sangon (Shanghai, China). 0 (forward) and 5 0 -GAGACCCT CCACCTTGTCCA-3 0 (reverse). In addition, the housekeeping gene encoding b-actin was also detected as the endogenous control, 24 and primers for quantitative real-time PCR were designed as 5 0 -GATCATTGCTCCTCCTGAGC-3 0 (forward) and 5 0 -CACCTTCACCGTTCCAGTTT-3 0 (reverse) on the basis of the reference sequence (GenBank accession number: NM_001101). Quantitative real-time PCR was performed with LightCycler 1.5 (Roche Diagnostics, Mannheim, Germany), and data analysis was carried out as described. 25 mRNA levels of AGT were normalized to those of b-actin, and the fold changes of mRNA levels were presented as 2
. Single amplification of each PCR product was verified by melting curve analysis.
G3PDH activity assay under RNAi
Cells were harvested into a prechilled microtube using 200 ml of an ice-cold 50 mmol l À1 trihydroxymethyl aminomethane hydrochloride solution (pH 7.5) containing 1 mmol l À1 EDTA and 100 nmol l À1 b-mercaptoethanol after being washed thrice with phosphate-buffered solution (pH 7.4) on days 3, 9 and 15. Subsequently, cells were disintegrated using sonication in an ice-water bath, and the supernatant was obtained after a centrifugation at 12 000 g for 15 min at 4 1C. The solution for analysis of G3PDH activity contained 100 mmol l Absorbance at 340 nm was monitored spectrophotometrically at 37 1C with an interval of 30 s for 3 min, whereas the protein concentration of the supernatant was quantitated as described. 26 The unit of G3PDH activity was milliunits (mU)
per milligram (mg) of supernatant protein, and 1 mU of enzymatic activity indicated that 1 nmol nicotinamideadenine dinucleotide was completely oxidized in 1 min.
Changes of intracytoplasmic lipids caused by RNAi
Analysis of intracytoplasmic lipids content of transfectants during HPA-v differentiation was performed as described. 27 First, after being harvested and washed with phosphatebuffered solution (pH 7.4) three times, cells were fixed with 10% formalin in isotonic phosphate-buffered solution for at least 30 min on days 0, 3, 6, 9, 12 and 15. Second, the cells were washed with 500 ml 60% isopropanol (per well), and the remnant was volatilized in about 5 min. Third, cells were stained with 300 ml working solution of Oil Red O for 2 h.
Fourth, the stain solution was removed and cells were rinsed in 500 ml of 60% isopropanol for 5 s. Finally, the dye was extracted by 700 ml of 60% isopropanol and quantitated spectrophotometrically at 510 nm. In addition, adipocytes were observed using a Leica DM IRB inverted phase contrast microscope (Leica, Heidelberg, Germany) on day 15.
Statistical analysis
In this study, data are presented as mean value ± s.d. of three independent experiments. Statistically significant differences between groups were determined by Student's t-test and analysis of variance. A P-value less than 0.05 was considered as a statistically significant difference, whereas the difference was defined as extremely significant at a P-value less than 0.01.
Results
Construction of recombinant plasmid against AGT mRNA Two AGT-targeting plasmids and a negative control plasmid have been constructed as psiRNA-AGT1, psiRNA-AGT2 and psiRNA-AGT0 on the basis of the H1 promoter-driven expression vector psiRNA-hH1neo with annealed doublestranded oligonucleotide fragments psi-AGT1, psi-AGT2 and psi-AGT0, respectively (Table 1) . Each annealed oligonucleotide fragment was inserted downstream of the human H1 promoter of psiRNA-hH1neo linear plasmid. Successful recombinant plasmids have been identified by the digestion of AseI and DNA sequencing. Under the digestion of AseI, the psiRNA-hH1neo vector generates two fragments (2227 and 752 bp), and the successful recombinant plasmids become linear (2670 bp).
Downregulation of AGT expression by RNAi
Quantitative real-time RT-PCR was performed to measure the mRNA levels of AGT in HPA-v on day 2. The result demonstrated that both AGT-targeting plasmids psiRNA-AGT1 and psiRNA-AGT2 reached an extremely significant difference on suppressing AGT expression compared with the negative control group (0.38 ± 0.04 vs 1.00 ± 0.06: Po0.01; 0.46 ± 0.03 vs 1.00 ± 0.06: Po0.01) (Figure 1 ). The mRNA levels in psiRNA-AGT1-transfected preadipocytes were decreased by about 62%, whereas a 54% downregulation of AGT mRNA levels in psiRNA-AGT2-transfected preadipocytes was detected versus that in the negative control group. Therefore, these two shRNA-mediated interference plasmids have been successfully constructed to silence the expression of the AGT gene to a certain extent.
Analysis of G3PDH activity during HPA-v differentiation under RNAi
The G3PDH activity of HPA-v with AGT-targeting plasmids was investigated after 3, 6 and 15 days of differentiation. In (Figure 2 ). Furthermore, on day 6, the G3PDH activity of psiRNA-AGT1-transfected cells reached an extremely significant difference compared with that of the negative control group (147.93±9.64 vs 189.74 ± 10.72: Po0.01).
Effects of AGT-targeting plasmids on intracytoplasmic lipids accumulation during HPA-v differentiation During preadipocytes differentiation, intracytoplasmic lipids accumulate massively, and the amount of intracytoplasmic lipids content determines the process of preadipocyteadipocyte conversion. Consistent with the expectation, preadipocytes accumulated intracytoplasmic lipids during the process of differentiation irrespective of which plasmid has been chosen to transfect cells ( Figure 3 ). As showed in Figure 3 , the lipids content of both psiRNA-AGT1-and psiRNA-AGT2-transfected cells was lower than that of the negative control group. In other words, both shRNA interference plasmids, psiRNA-AGT1 and psiRNA-AGT2, affected the inhibition of the accumulation of intracytoplasmic lipids. The intracytoplasmic lipids content of psiRNA-AGT1-transfected cells reached a statistically significant difference on days 6, 9 and 12 compared with that of the negative control group (9.50±1.83 vs 13.56±1. . It was shown that the effect on suppressing the intracytoplasmic lipids accumulation of psiRNA-AGT1 was stronger than that of psiRNA-AGT2. However, the decreased intracytoplasmic lipids content of both AGT-targeting plasmids-transfected cells was statistically insignificant at a later stage of HPA-v differentiation (psiRNA-AGT1-transfected cells over day 12, psiRNA-AGT1-transfected cells over day 9) compared with that of the negative control group. On the whole, AGT expression was related to intracytoplasmic lipids accumulation in some way. The photomicrographs of adipocytes without or with plasmids have been observed after 15 days of differentiation ( Figure 4 AGT knockdown inhibits HPA-v differentiation Z-W Ye et al psiRNA-AGT1-and psiRNA-AGT2-transfected cells was lower than that of the negative control group. Moreover, in agreement with the result above, the suppressing effect on intracytoplasmic lipids accumulation of psiRNA-AGT1 was stronger than that of psiRNA-AGT2.
Discussion
The gene-silencing process of RNAi is an ancient mechanism responsible for the epigenetic phenomenon, and it is well recognized as a cellular immune system for protecting the genome against molecular parasites including viruses and transposons. 28 During this process, mRNA of target gene is guided to degrade under the induction of complementary base pairing between small interfering RNA (siRNA) and mRNA. 29 It has been indicated that RNAi was an available and effective sequence-specific reagent in suppressing the gene expression in cultured mammalian cells. 21, 30, 31 Currently, RNAi is a powerful tool for controlling the expression of interested gene in altering the phenotype of cells and even the whole organism. 32, 33 It is possible that
RNAi can become a gene-specific therapeutic strategy for suppressing the expression of problem genes. 21, 29 Obesity is highly prevalent across the world as a result of a high-calorie and high-fat diet, as well as because of decreased energy expenditure. According to the announcement of 
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Professor Philip James, the chair of the International Obesity Task Force (IOTF), 34 there are approximately 1.7 billion people who are obese around the world. It is generally believed that obesity is a symptom concerned with a wide range of serious medical conditions. It is universally recognized that the immediate cause of obesity is the massive accumulation of subcutaneous and visceral fat resulting from the massive accumulation of intracytoplasmic lipids of adipocytes, accompanied by the increased number of these cells. 35 In consequence, a clearer understanding of the molecular mechanisms underlying adipogenesis and obesity development is urgent and crucial in establishing therapeutic strategies against worldwide obesity and obesity-associated health problems. Moreover, a purposeful control of preadipocytes differentiation also performs essential roles in the highly demanded plastic and reconstructive surgical procedures. The differentiation of preadipocytes is a complex process that includes a cascade of transcriptional events that culminate in the expression of C/EBPs, proliferator-activated receptor-g and adipocyte determination-and differentiationdependent factor 1 in rodent or sterol regulatory elementbinding protein-1 in humans. 20, 36 Subsequently, these vital transcription factors mediated the transcriptional control of relative genes that were required for the conversion of preadipocytes to adipocytes. Previous studies have indicated that antisense RNA against the mRNA of C/EBPa suppressed the differentiation of preadipocytes, whereas the ectopic expression of C/EBPa promoted this process. 37, 38 It was shown that C/EBPa activated several genes, such as AGT, adipocyte protein-2 and stearoyl-CoA desaturase during preadipocytes differentiation. 36, 39 Ang II, uniquely generated from AGT, could stimulate the production and release of prostacyclin, which promotes the process of preadipocytes differentiation subsequently. 40 It was suggested that Ang II is implicated in preadipocytes differentiation by increasing TAG content and lipogenic enzymes activity significantly. [8] [9] [10] However, contrary effects were also proposed by other researchers. [41] [42] [43] Schling and Löffler 41 showed that Ang II significantly reduced the differentiation of insulin-induced human preadipocytes. Saiki et al. 43 demonstrated that the addition of Ang II caused the suppression of adipogenic differentiation of 3T3-L1 cells, and they suggested that inhibited differentiation may result from the activation of RAS in preadipocytes.
The primary purpose of this study was to construct shRNAmediated gene-silencing vectors to inhibit the expression of AGT and to investigate the influence on the differentiation of human visceral preadipocytes subsequently. On the basis of the H1 promoter-driven expression vector psiRNAhH1neo (InvivoGen), we have successfully constructed two shRNA-mediated gene-silencing vectors against AGT expression. According to results, these two shRNA-mediated gene-silencing vectors, psiRNA-AGT1 and psiRNA-AGT2, decreased the expression of AGT by about 62 and 54%, respectively, compared with the negative control group (Figure 1) . Intracytoplasmic lipids content is a yardstick for measuring the process of preadipocyte-adipocyte conversion. Previously, it was shown that in HPA-v, the content of intracytoplasmic lipids, as well as the enzymatic activity of G3PDH, increased along with the elapse of differentiation time. 18 Similarly, in this study, intracytoplasmic lipids content increased during the process of HPA-v differentiation in all cases, with or without the interference of plasmids ( Figure 3 ). As shown in Figure 3 , both AGT-targeting plasmids (psiRNA-AGT1 and psiRNA-AGT2) had a part in the decreased accumulation of intracytoplasmic lipids in the whole process of differentiation compared with the negative control group. Consistent with the decrease in AGT expression, the effect on suppressing intracytoplasmic lipids of psiRNA-AGT1 was stronger than that of psiRNA-AGT2 (Figures 1 and 3) . As the suppression of AGT expression caused the inhibition of intracytoplasmic lipids accumulation, and the decrease in intracytoplasmic lipids content was in direct proportion to the strength of suppression of AGT expression (comparison between psiRNA-AGT1 and psiRNA-AGT2 groups) (Figures 1 and 3) , we speculated that the sole precursor of Ang II, AGT, contributes to the deposition of intracytoplasmic lipids and preadipocytes differentiation.
It is interesting that under RNAi, the intracytoplasmic lipids content decreased by about 30% (psiRNA-AGT1 vs psiRNA-AGT0 (day 6): 9.50 ± 1.83 vs 13.56 ± 1.18) or even less, and the decrease in intracytoplasmic lipids was insignificant after 15 days (Figure 3) , although the mRNA levels of AGT decreased by more than 50% (Figure 1) . In other words, it seems that intracytoplasmic lipids accumulation was not exclusively determined by the expression of AGT, it may also be regulated by other factors. It has been indicated for long that accumulation of TAG occurred after the generation of G3PDH in adipocytes. 44 It was shown that the enzymatic activity of G3PDH and fatty acid synthase enhanced during TAG accumulation in adipocytes. 8 However, it was also considered that TAG accumulation in adipocytes was predominantly attributed to the elevated activity of G3PDH owing to the low activity of glycerokinase, fatty acid synthase and adenosine triphosphate-citrate lyase. 45, 46 Currently, G3PDH activity significantly decreased both in psiRNA-AGT1-and psiRNA-AGT2-transfected cells compared with the negative control group (Figure 2 ). Moreover, G3PDH activity decreased by 22% (psiRNA-AGT1 vs psiRNA-AGT0 (day 6):147.93 ± 9.64 vs 189.74 ± 10.72) or less. With regard to the decreased extent of lipids content, it is suggested that the accumulation of intracytoplasmic lipids was performed definitively by G3PDH during HPA-v differentiation. Moreover, G3DPH may be regulated by the expression of AGT, but not exclusively, as the decrease in AGT expression is much higher than that of G3PDH activity. As a result, the regulatory mechanism for the expression and activation of G3PDH during preadipocytes differentiation should be clarified in future study. Obesity has become a serious health problem around the world owing to high energy-dense food and the lack of physical exercise. Owing to the close relationship between obesity and a considerable variety of terrible diseases, a lot of people are placed in distressing circumstances throughout the world. In addition, plenty of plastic and reconstructive surgical procedures are performed each year to repair adipose tissue defects. However, the short-term differentiation capability of preadipocytes is a real hindrance in performing adipose tissue engineering. 35 Moreover, there are still lots of unclear and controversial events regarding the mechanisms of preadipocytes differentiation. Consequently, a clear identification of the underlying molecular mechanisms of preadipocytes differentiation is urgent and critical. RNAi is a powerful tool for controlling the expression of specific genes, and it may be an effective therapeutic strategy for suppressing the expression of problem genes. In this study, we successfully constructed two shRNA-mediated AGT-targeting plasmids to suppress the process of HPA-v differentiation to a certain extent. It provided a method for inhibiting the process of preadipocytes differentiation, and it may have a role in obesity treatment and adipose tissue engineering application.
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